Alovudine 18F Injection is a radiopharmaceutical belonging to the fluoropyrimidine class, frequently utilized as a positron emission tomography (PET) tracer for the non-invasive imaging of cellular proliferation… Read more
Alovudine 18F Injection is a radiopharmaceutical belonging to the fluoropyrimidine class, frequently utilized as a positron emission tomography (PET) tracer for the non-invasive imaging of cellular proliferation and hypoxia in solid tumors, such as non-small cell lung cancer. Accurate characterization of this tracer relies on high-quality reference standards, including the active pharmaceutical ingredient, potential synthetic impurities, and related metabolites. Analytical laboratories require these materials to perform rigorous impurity profiling, method validation, and ongoing quality control of the radiopharmaceutical product. By utilizing well-defined analytical standards, researchers can ensure the consistency and reliability of FLT-PET imaging, supporting standardized assessments of tumor dynamics and treatment response monitoring in clinical research and developmental settings.